Swine/procine Delta Coronavirus nucleocapsid (N) antibody and antigen (recombinant protein)
Diagnostic anti-Swine/procine Delta Coronavirus nucleocapsid (N) antibodies pairs and antigen for animal health (animal Swine/Porcine/Pig infectious disease porcine diarrhea) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT
Go to Swine/Porcine/Pig disease testing products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-VT-P104-Tg002-Ag01 | Recombinant Swine/procine Delta Coronavirus nucleocapsid (N) protein | $3090.00 |
GMP-VT-P104-Tg002-Ab01 | Anti-Swine/procine Delta Coronavirus nucleocapsid (N) mouse monoclonal antibody (mAb) | $3090.00 |
GMP-VT-P104-Tg002-Ab02 | Anti-Swine/procine Delta Coronavirus nucleocapsid (N) mouse monoclonal antibody (mAb) | $3090.00 |
GMP-VT-P104-Tg002-Ab03 | Anti-Swine/procine Delta Coronavirus nucleocapsid (N) human monoclonal antibody (mAb) | $3090.00 |
GMP-VT-P104-Tg002-Ab04 | Anti-Swine/procine Delta Coronavirus nucleocapsid (N) human monoclonal antibody (mAb) | $3090.00 |
Size: 1mg | 10mg | 100mg
Product Description
Cat No. | GMP-VT-P104-Tg002-Ag01 |
Product Name | Recombinant Swine/procine Delta Coronavirus nucleocapsid (N) protein |
Pathogen | Swine/procine Delta Coronavirus |
Expression platform | E.coli |
Isotypes | Recombinant Antigen |
Bioactivity validation | Anti-Swine/procine Delta Coronavirus nucleocapsid (N) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in Swine/procine Delta Coronavirus level test of animal Swine/Porcine/Pig infectious disease with porcine diarrhea. |
Tag | His | Product description | Recombinant Swine/procine Delta Coronavirus nucleocapsid (N) proteinwas expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays. |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. | GMP-VT-P104-Tg002-Ab01,GMP-VT-P104-Tg002-Ab02 |
Pathogen | Swine/procine Delta Coronavirus |
Product Name | Anti-Swine/procine Delta Coronavirus nucleocapsid (N) mouse monoclonal antibody (mAb) |
Expression platform | CHO |
Isotypes | Mouse IgG |
Bioactivity validation | Recombinant Swine/procine Delta Coronavirus nucleocapsid (N) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Swine/procine Delta Coronavirus antibodies in Swine/procine Delta Coronavirus level test of animal Swine/Porcine/Pig infectious disease with porcine diarrhea. |
Product description | Anti-Swine/procine Delta Coronavirus nucleocapsid (N) mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Swine/procine Delta Coronavirus antibodies. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays. |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. | GMP-VT-P104-Tg002-Ab03,GMP-VT-P104-Tg002-Ab04 |
Pathogen | Swine/procine Delta Coronavirus |
Product Name | Anti-Swine/procine Delta Coronavirus nucleocapsid (N) human monoclonal antibody (mAb) |
Expression platform | CHO |
Isotypes | Human lgG1 |
Bioactivity validation | Recombinant Swine/procine Delta Coronavirus nucleocapsid (N) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Swine/procine Delta Coronavirus antibodies in Swine/procine Delta Coronavirus level test of animal Swine/Porcine/Pig infectious disease with porcine diarrhea. |
Product description | Anti-Swine/procine Delta Coronavirus nucleocapsid (N) mouse monoclonal antibody (mAb) is a human monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays. |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Pathogen Information
1. Genes or Proteins Targeted:
The genes or proteins targeted for diagnostic purposes are crucial in identifying and confirming the presence of Swine/Porcine Delta Coronavirus. Researchers and diagnosticians focus on specific regions of the viral RNA genome. Notably, genes encoding vital viral components like the spike protein are of particular interest. The spike protein plays a significant role in viral entry into host cells and is therefore a key target for detection.
2. RT-PCR tests:
Reverse Transcription Polymerase Chain Reaction (RT-PCR) tests are employed to amplify and detect specific regions of the viral RNA genome. In the case of Swine/Porcine Delta Coronavirus, these tests primarily aim at identifying genes responsible for encoding crucial proteins like the spike protein. This method enables precise and sensitive detection of the virus.
3. ELISAs:
Enzyme-Linked Immunosorbent Assays (ELISAs) are serological tests designed to detect antibodies produced by the host's immune system in response to viral infection. For Swine/Porcine Delta Coronavirus, ELISAs target antibodies directed against key viral proteins, such as the spike (S) protein and nucleocapsid (N) protein. This approach aids in confirming exposure to the virus and assessing the immune response in swine populations.
4. Prevention and Control:
Effective prevention and control strategies are essential in mitigating the impact of Swine/Porcine Delta Coronavirus on swine populations and the agricultural industry as a whole.
5. Biosecurity measures:
Stringent biosecurity measures are paramount. These include practices such as isolating and quarantining infected pigs, implementing thorough sanitation protocols, and regulating access to farms. These measures collectively form a critical barrier against the spread of the virus within and across swine farming operations.
6. Vaccination:
Development and administration of vaccines tailored to the specific strain of Swine/Porcine Delta Coronavirus are crucial for proactive prevention. These vaccines aim to bolster the immune response in swine populations, reducing the severity of infections and minimizing transmission.
7. Monitoring and surveillance:
Regular testing and vigilant monitoring for the presence of the virus are essential components of early detection and control efforts. This proactive approach allows for swift intervention in the event of an outbreak, limiting its potential impact.
8. Research and Vaccine Development:
Ongoing research endeavors are dedicated to deepening our understanding of Swine/Porcine Delta Coronavirus. This encompasses studying its genetic evolution, pathogenesis, and immune responses. Collaborations with veterinary and agricultural institutions play a pivotal role in advancing knowledge and developing effective solutions, including vaccines.
9. Economic Impact:
Swine/Porcine Delta Coronavirus can exert a substantial economic toll on the swine industry. Factors contributing to this impact include reduced growth rates, elevated mortality rates among piglets, and the costs associated with implementing control measures. Addressing this virus is imperative to sustain a healthy and economically viable swine farming sector.
10. Conclusion:
In summary, Swine/Porcine Delta Coronavirus is a deltacoronavirus primarily affecting swine, giving rise to gastrointestinal and respiratory symptoms. Importantly, it is not transmissible to humans and is categorized as a livestock virus. Accurate diagnostic methods, including nucleic acid tests and serological assays, are instrumental in identifying and managing outbreaks. Robust prevention and control strategies, ongoing research initiatives, and targeted vaccine development are pivotal in safeguarding the swine industry from the economic impact of this virus.
This comprehensive information provides a detailed overview of Swine/Porcine Delta Coronavirus, covering its characteristics, diagnostic methods, prevention, and economic implications, making it a valuable resource for marketing and informational purposes.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.